Literature DB >> 17356846

Roles of PPARs on regulating myocardial energy and lipid homeostasis.

Qinglin Yang1, Yuhao Li.   

Abstract

Myocardial energy and lipid homeostasis is crucial for normal cardiac structure and function. Either shortage of energy or excessive lipid accumulation in the heart leads to cardiac disorders. Peroxisome proliferator-activated receptors (PPARalpha, -beta/delta and -gamma), members of the nuclear receptor transcription factor superfamily, play important roles in regulating lipid metabolic genes. All three PPAR subtypes are expressed in cardiomyocytes. PPARalpha has been shown to control transcriptional expression of key enzymes that are involved in fatty acid (FA) uptake and oxidation, triglyceride synthesis, mitochondrial respiration uncoupling, and glucose metabolism. Similarly, PPARbeta/delta is a transcriptional regulator of FA uptake and oxidation, mitochondrial respiration uncoupling, and glucose metabolism. On the other hand, the role of PPARgamma on transcriptional regulation of FA metabolism in the heart remains obscure. Therefore, both PPARalpha and PPARbeta/delta are important transcriptional regulators of myocardial energy and lipid homeostasis. Moreover, it appears that the heart needs to have two PPAR subtypes with seemingly overlapping functions in maintaining myocardial lipid and energy homeostasis. Further studies on the potential distinctive roles of each PPAR subtype in the heart should provide new therapeutic targets for treating heart disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17356846     DOI: 10.1007/s00109-007-0170-9

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   5.606


  81 in total

Review 1.  Myocardial substrate metabolism in the normal and failing heart.

Authors:  William C Stanley; Fabio A Recchia; Gary D Lopaschuk
Journal:  Physiol Rev       Date:  2005-07       Impact factor: 37.312

2.  Diabetes and the heart: state of the art in the 1990s.

Authors:  S Zoneraich; J L Mollura
Journal:  Can J Cardiol       Date:  1993-05       Impact factor: 5.223

3.  A role for peroxisome proliferator-activated receptor alpha (PPARalpha ) in the control of cardiac malonyl-CoA levels: reduced fatty acid oxidation rates and increased glucose oxidation rates in the hearts of mice lacking PPARalpha are associated with higher concentrations of malonyl-CoA and reduced expression of malonyl-CoA decarboxylase.

Authors:  Fiona M Campbell; Ray Kozak; Alese Wagner; Judith Y Altarejos; Jason R B Dyck; Darrell D Belke; David L Severson; Daniel P Kelly; Gary D Lopaschuk
Journal:  J Biol Chem       Date:  2001-12-04       Impact factor: 5.157

4.  The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus.

Authors:  Brian N Finck; John J Lehman; Teresa C Leone; Michael J Welch; Michael J Bennett; Attila Kovacs; Xianlin Han; Richard W Gross; Ray Kozak; Gary D Lopaschuk; Daniel P Kelly
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

5.  Lipoprotein secretion and triglyceride stores in the heart.

Authors:  J Bjorkegren; M Véniant; S K Kim; S K Withycombe; P A Wood; M K Hellerstein; R A Neese; S G Young
Journal:  J Biol Chem       Date:  2001-07-31       Impact factor: 5.157

6.  Peroxisome proliferator-activated receptor gamma activators inhibit cardiac hypertrophy in cardiac myocytes.

Authors:  K Yamamoto; R Ohki; R T Lee; U Ikeda; K Shimada
Journal:  Circulation       Date:  2001-10-02       Impact factor: 29.690

7.  The new antidiabetic drug MCC-555 acutely sensitizes insulin signaling in isolated cardiomyocytes.

Authors:  L S Liu; H Tanaka; S Ishii; J Eckel
Journal:  Endocrinology       Date:  1998-11       Impact factor: 4.736

8.  Lipoprotein clearance mechanisms in LDL receptor-deficient "Apo-B48-only" and "Apo-B100-only" mice.

Authors:  M M Véniant; C H Zlot; R L Walzem; V Pierotti; R Driscoll; D Dichek; J Herz; S G Young
Journal:  J Clin Invest       Date:  1998-10-15       Impact factor: 14.808

9.  Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size.

Authors:  Nicole S Wayman; Yoshiyuki Hattori; Michelle C McDonald; Helder Mota-Filipe; Salvatore Cuzzocrea; Babrbara Pisano; Prabal K Chatterjee; Christoph Thiemermann
Journal:  FASEB J       Date:  2002-07       Impact factor: 5.191

10.  Effects of chronic right ventricular pressure overload on myocardial glucose and free fatty acid metabolism in the conscious rat.

Authors:  D Takeyama; Y Kagaya; Y Yamane; N Shiba; M Chida; T Takahashi; T Ido; N Ishide; T Takishima
Journal:  Cardiovasc Res       Date:  1995-06       Impact factor: 10.787

View more
  39 in total

1.  Enhancing fatty acid oxidation negatively regulates PPARs signaling in the heart.

Authors:  ZhengLong Liu; Jeffrey Ding; Timothy S McMillen; Outi Villet; Rong Tian; Dan Shao
Journal:  J Mol Cell Cardiol       Date:  2020-06-24       Impact factor: 5.000

2.  Arctigenin enhances swimming endurance of sedentary rats partially by regulation of antioxidant pathways.

Authors:  Ruo-ming Wu; Yan-yan Sun; Ting-ting Zhou; Zhi-yuan Zhu; Jing-jing Zhuang; Xuan Tang; Jing Chen; Li-hong Hu; Xu Shen
Journal:  Acta Pharmacol Sin       Date:  2014-08-25       Impact factor: 6.150

Review 3.  Metabolic alterations induce oxidative stress in diabetic and failing hearts: different pathways, same outcome.

Authors:  David Roul; Fabio A Recchia
Journal:  Antioxid Redox Signal       Date:  2015-04-30       Impact factor: 8.401

Review 4.  Regulation of mitochondrial ATP synthase in cardiac pathophysiology.

Authors:  Qinqiang Long; Kevin Yang; Qinglin Yang
Journal:  Am J Cardiovasc Dis       Date:  2015-03-20

5.  Characterization of the mechanisms of the increase in PPARδ expression induced by digoxin in the heart using the H9c2 cell line.

Authors:  Zhih-Cherng Chen; Bu-Chin Yu; Li-Jen Chen; Kai-Chun Cheng; Hung Jung Lin; Juei-Tang Cheng
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

Review 6.  Mitochondrial function in vascular endothelial cell in diabetes.

Authors:  Meenal Pangare; Ayako Makino
Journal:  J Smooth Muscle Res       Date:  2012

Review 7.  Sphingolipids, lipotoxic cardiomyopathy, and cardiac failure.

Authors:  Tae-Sik Park; Ira J Goldberg
Journal:  Heart Fail Clin       Date:  2012-08-10       Impact factor: 3.179

8.  Effect of Cheonggukjang supplementation upon hepatic acyl-CoA synthase, carnitine palmitoyltransferase I, acyl-CoA oxidase and uncoupling protein 2 mRNA levels in C57BL/6J mice fed with high fat diet.

Authors:  Ju-Ryoun Soh; Dong-Hwa Shin; Dae Young Kwon; Youn-Soo Cha
Journal:  Genes Nutr       Date:  2008-02       Impact factor: 5.523

9.  Peroxisome proliferator-activated receptor {delta} is an essential transcriptional regulator for mitochondrial protection and biogenesis in adult heart.

Authors:  Peiyong Wang; Jian Liu; Yuquan Li; Sijie Wu; Jinwen Luo; Huan Yang; Ramasamy Subbiah; John Chatham; Olga Zhelyabovska; Qinglin Yang
Journal:  Circ Res       Date:  2010-01-14       Impact factor: 17.367

10.  Reduction of rat cardiac hypertrophy by osthol is related to regulation of cardiac oxidative stress and lipid metabolism.

Authors:  Feng Zhou; Wen Zhong; Jie Xue; Zhen-lun Gu; Mei-lin Xie
Journal:  Lipids       Date:  2012-08-24       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.